You are here

  • Home
  • Archive
  • Volume 101, Issue 6
  • Ocular hypotensive effect of the novel EP3/FP agonist ONO-9054 versus Xalatan: results of a 28-day, double-masked, randomised study

Article metrics

Article menu

Download PDFPDF

Clinical science
Ocular hypotensive effect of the novel EP3/FP agonist ONO-9054 versus Xalatan: results of a 28-day, double-masked, randomised study

 

Online download statistics by month:

Online download statistics by month: September 2016 to November 2023

AbstractFullPdf
Sep 201638730179
Oct 201627025069
Nov 2016834523
Dec 201638266
Jan 201724286
Feb 201761811
Mar 20170195
Apr 201703514
May 2017111521
Jun 20179423972
Jul 201712212040
Aug 2017777425
Sep 201711811615
Oct 201719719411
Nov 201711010719
Dec 201790889
Jan 201867668
Feb 201868627
Mar 2018696710
Apr 201861589
May 2018666911
Jun 2018414212
Jul 201863625
Aug 201859599
Sep 201844443
Oct 2018555510
Nov 201863625
Dec 201869607
Jan 2019786711
Feb 2019867116
Mar 2019604619
Apr 2019412611
May 2019544416
Jun 201947399
Jul 201965578
Aug 2019524615
Sep 201947397
Oct 2019645111
Nov 2019513910
Dec 201939297
Jan 20201049811
Feb 202060487
Mar 202058455
Apr 2020444014
May 2020504411
Jun 202049357
Jul 202033281
Aug 202032246
Sep 202044374
Oct 202022224
Nov 2020271911
Dec 2020463714
Jan 202127277
Feb 202113138
Mar 202115158
Apr 2021994
May 2021775
Jun 202116162
Jul 2021161612
Aug 2021664
Sep 202115158
Oct 2021171525
Nov 2021505018
Dec 202121229
Jan 202217173
Feb 202223214
Mar 202224168
Apr 202217173
May 2022343217
Jun 202222207
Jul 202217153
Aug 202238356
Sep 2022333016
Oct 202229267
Nov 202216166
Dec 2022642
Jan 202313137
Feb 202329283
Mar 202315104
Apr 202313105
May 2023849
Jun 2023121210
Jul 202310611
Aug 2023211611
Sep 20231195
Oct 20231487
Nov 202319182
Total424841061022